Columbia Study Shows Base Editing Edits Embryos Safely
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- CRISPR base editing was used by a U.S. research team to edit healthy embryos without introducing unwanted mutations.
- Dieter Egli at Columbia University conducted a larger study on healthy two‑cell embryos donated by parents, achieving a 75% success rate for one edit with no off‑target changes.
- CRISPR‑Cas9 cuts both DNA strands, often causing large mutations and chromosomal abnormalities, which base editing avoids by cutting only a single strand.
- Guide RNAs design impacted outcomes: one edit succeeded in ~75% of cells, while another succeeded in ~50% and produced unwanted changes, suggesting better guide design could improve reliability.
Why it matters: Parents seeking genetic disease prevention could benefit if the technique becomes reliable, but current guide‑RNA limitations mean off‑target edits remain a risk, slowing clinical translation.
